AVANTGEN INC
AVANTGEN INC is a federal contractor, registered under UEI WLNHKNPNT2M7 and CAGE code 4NTY2. It has been awarded $18,737,392 in federal contracts. Primary work spans Unknown NAICS, Analytical Laboratory Instrument Manufacturing, and Research and Development in Biotechnology. Top awarding agencies include Department Of Health And Human Services.
Contact Information
Registration and classification details
Registration
UEI Code
WLNHKNPNT2M7CAGE Code
4NTY2Entity Structure
Corporate Entity (Not Tax Exempt)Established
N/ABusiness Classifications
NAICS Codes
Federal Contracting Overview
Award totals, agency breakdown, NAICS distribution, and geographic footprint.
AI Capability Profile
AvantGen Inc. specializes in the development of non-mouse reagents for preclinical biomedical research, with a focused expertise in rabbit monoclonal antibody production for non-traditional animal models such as ferrets and Indian flying foxes. Their technical capabilities center on biomarker discov...
AvantGen Inc. specializes in the development of non-mouse reagents for preclinical biomedical research, with a focused expertise in rabbit monoclonal antibody production for non-traditional animal models such as ferrets and Indian flying foxes. Their technical capabilities center on biomarker discovery, antibody validation, and the creation of species-specific diagnostic tools that enable translational research beyond murine systems. This niche specialization allows for more physiologically relevant modeling of human disease pathways, particularly in infectious disease and immunotherapy development. The company demonstrates deep proficiency in immunoassay design, antigen selection, hybridoma technology, and cross-species reagent characterization, filling a critical gap in the preclinical toolkit where mouse models are insufficient. AvantGen maintains a consistent relationship with the Department of Health and Human Services, delivering research and development services that support the advancement of novel therapeutics. Their work directly enables HHS-funded programs to overcome limitations in existing animal models by providing validated, non-mouse reagents essential for evaluating candidate drugs in more predictive biological systems. This pattern reflects a strategic alignment with HHS priorities in pandemic preparedness, zoonotic disease research, and alternative model development. The contractor’s primary focus lies in NAICS 541714 and 541715, which encompass biotechnology R&D and broader life sciences innovation excluding nanotechnology. In practice, this translates to targeted R&D in immunology, comparative biology, and translational biomarker science—positions AvantGen as a specialized provider in the preclinical reagent development market. AvantGen Inc. is a small business structured as a 2L entity, headquartered in San Diego, California. While currently holding no formal government certifications, its technical precision and focus on high-value, non-standard biological reagents establish a distinct market position within the federal biomedical research ecosystem.
Key Performance Metrics
Awards Count
24
All time
Active
1
Currently performing
Completed
23
Past period of performance
Total Awards
All time
Contracts
Prime · all time
Subcontracts
Sub · all time
Grants
Prime · all time
Subgrants
Sub · all time
Award Analytics & Distribution
Compete with AVANTGEN INC
Track the contractors you bid against, and the work they win
Award history, agency mix, and NAICS coverage for AVANTGEN INC
AI-powered matching against your own capabilities and past performance
Teaming and subcontracting signals on every award
Automated alerts when a competitor wins in your market
Join 750+ contractors already using CLEATUS
